In Phase One, we met some of the most iconic characters in the MCU, but which origin story was the most entertaining?

UCI’s $12M CIRM award for hNSC-01 marks a pivotal shift to clinical-stage development. See how this state-funded "bridge" is ...

Dynavax's adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than ...

Silver is turning into one of the hottest trades of 2025. Why this veteran investor is targeting $300 in a coming 'mania' ...

Ambros Therapeutics launches with $125M to advance neridronate, a non-opioid therapy for CRPS-1. See how this Phase 3-ready ...

No side has conceded more goals from set-pieces (ex. pens) than Liverpool in the Premier League this season - or indeed in ...

There is a new cheap crypto that is attracting massive attention in the marketplace. Mutuum Finance (MUTM), is currently ...

More than 30 years after New York City switched from tokens to the magnetic swipe of a MetroCard to ride its subways and ...

Momentum is quietly building around a new crypto that has stayed mostly under the radar compared to large-cap names. While ...

From shadow-heavy visuals and glowing vintage televisions to the striking use of a single Hanja character, everything about ...

The headline that accompanied confirmation conveyed exactly why Al Qadsiah had acted so decisively.“Al Qadsiah appoints European coaching giant Brendan Rodgers as Head Coach”, declared the ...

See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...